肺部康复计划减少了慢性阻塞性肺病患者住院的次数:一个成本效益研究
Maria Elena Toubes-Navarro1, Francisco Gude-Sampedro2, José Manuel Álvarez-Dobaño3,4
1Department of Pulmonology, University Clinical Hospital of Santiago de Compostela, Spain.
Annals of thoracic medicine
|December 7, 2023
概括
肺部康复 (PR) 显著减少慢性阻塞性肺病 (COPD) 患者的恶化和住院. 该计划具有成本效益,改善生活质量并节省医疗保健成本.
科学领域:
- 肺部医学 肺部医学
- 卫生经济学 卫生经济学
背景情况:
- 建议COPD患者进行肺部康复 (PR).
- 关于PR的成本效益和对恶化的影响的数据有限.
研究的目的:
- 评估PR在减少恶化的成本效益和有效性.
- 评估PR对COPD患者的生活质量和医疗保健成本的影响.
主要方法:
- 一项涉及200名COPD患者的准实验性研究.
- 恶化,生活质量 (COPD评估测试,EuroQol-5D) 和成本在PR之前和之后被测量.
- 增量成本效益比率 (ICER) 计算使用经质量调整的寿命年 (QALYs).
主要成果:
- 在PR后的入院 (48.2%),住院 (46.6%) 和急救访问 (42.5%) 显著减少 (P < 0.001).
- 生活质量得分显著改善 (P < 0.001).
- 公共公共服务带来了1826欧元/患者/年的成本节约和+0.107个QALY的收益,ICER为-17,056欧元.
结论:
- PR有效地减少了恶化,并减缓了COPD的临床恶化.
- 公共公共服务是一种具有成本效益的干预措施,改善了患者的生活质量并降低了医疗保健支出.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
214
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
214
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.9K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.9K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K


